Walden Group Healthcare M&A Blog

  • Medtronic to Acquire Intersect ENT

    8/24/2021
    Medtronic plc (Nasdaq: MDT), a $30.1b Ireland-based producer of devices used in cardiovascular, neuroscience, surgical, and diabetes management applications, is acquiring Intersect ENT (Nasdaq: XENT), a developer of an ENT implant that releases steroids during sinus surgery to manage inflammation and a virtual surgical guidance platform.  In...
    Read More
  • The Walden Group Releases Q2 2021 Strategic Healthcare M&A Report

    8/9/2021
    The Walden Group is pleased to provide access to its Q2 2021 Strategic Healthcare M&A Report, which includes:     Financings (IPOs, SPACs, private) and M&A Deals are surging     Major M&A Deals by Sector     What the CEOs of Leading Medtechs are Saying     Key Stats on Top Healthcare M&A Q2 Deals     Key Stats on...
    Read More
  • TopCon Acquires Italy-based Ophthalmic Imaging Device Producer VISIA Imaging

    7/26/2021
    TopCon Corporation, a $1.2 billion Japan-based developer of eyecare devices and software solutions worldwide has purchased Italy-based ophthalmic device manufacturer VISIA Imaging S.r.l.  The acquisition provides Topcon with a portfolio of imaging devices focused on the anterior segment to complement its existing posterior segment imaging...
    Read More
  • Surmodics Acquires Ireland–based Vetex Medical

    7/12/2021
    Surmodics, Inc., a $107m maker of surface modification technologies for intravascular medical devices, has acquired Vetex Medical Ltd, an Ireland–based producer of venous clot removal products. Vetex developed ReVene, a thrombectomy catheter platform that is used to remove, in a single session, large, mixed-morphology blood clots commonly found...
    Read More
  • Tecan Group Acquires Paramit for $1b

    6/29/2021
    Tecan Group Ltd, a $795m Switzerland-based global provider of laboratory instruments and solutions in life science research and clinical diagnostics, has acquired Paramit Corporation, a maker of electronics based medical devices and life science instruments. The deal accelerates Tecan's entry into medical devices and enhances Paramit's...
    Read More